Chemical | 25 June 2021
H.B. Fuller Q2 revenue up 22.7%
Based on current assumptions, full year 2021 revenue growth is anticipated to be in the low double-digits versus 2020
Based on current assumptions, full year 2021 revenue growth is anticipated to be in the low double-digits versus 2020
The company has been expanding technicals capacity by 10,000 MT with a total capex outlay of | 140 crore planned in the next two years.
Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials will be manufactured in the company’s North American manufacturing facility based in Monroe, North Carolina
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
The total size of the offer is Rs. 800 crores at the upper price band of Rs. 296 per share.
The company will distribute complete range of CP Kelco’s products
The transaction is expected to close in early July 2021
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
The company has predominantly built a portfolio into veterinary products
The company informed the bourses that it has allocated 81,08,107 shares at Rs. 296 per share on June 22, 2021 to anchor investors.
Shilpa's Paracetamol oral thin films are patent protected and are first of this kind in the world
The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end user know it is safe to use
These charging inlets are installed in battery electric vehicles and accommodate the charging coupler of the external charging station
The ESG-linked loan takes into account the company’s contributions to greater sustainability for the first time
The improvements at the plant, which produces ammonia and liquid UAN fertilizer, are to be completed this fall and build on other recent enhancements, including increasing ammonia loading capacity
The new product range is formulated with renewable and natural components, providing an environmentally friendly alternative to conventional inks without impacting the recyclability of paper, and board packaging taking a step towards reducing the microplastics which can be found in inks
With an enterprise value of USD 304 million, this is a decisive step in expanding Brenntag’s position in the North American Nutrition industry and a key acquisition aligned with Brenntag’s M&A strategy
Following the acquisition, Niacet will be integrated into Kerry’s global food protection and preservation platform
Evonik agrees to make a one-time cash payment of €66.55 million to Orion
During May, overall specialty chemicals volumes were up 13.7% on a year-over-year (Y/Y) basis, rebounding from the depressed levels of last year
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
